AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte Post author:Sam Post published:October 30, 2017 Post category:BioPharma Astra and Incyte are pushing forward on the development of immunotherapy combination treatments. Source: BioSpace You Might Also Like Apotex CEO Abruptly Resigns Amid Allegations of Trade Secret Leaks January 28, 2018 Ramaswamy's Roivant Inks $650M R&D Deal With This Tiny Diabetes Biotech February 11, 2018 Reata Pharmaceuticals, Inc. Announces First Quarter 2017 Financial And Operating Results May 10, 2017
Reata Pharmaceuticals, Inc. Announces First Quarter 2017 Financial And Operating Results May 10, 2017